Skip to main content

Table 2 Prevalence of high-risk human papillomavirus (HPV) in women with sufficient DNA for analyses in women living with HIV compared to women matched (1:5) on prior screening history and age from the general Danish population

From: Prevalence and distribution of cervical high-risk human papillomavirus and cytological abnormalities in women living with HIV in Denmark – the SHADE

  Women living with HIV 295 Women from the general population 1,475 p-value
High-risk HPV positive, n(%)
 Yes 78 (26.4) 245 (16.6) <0.0001
 No 217 (73.6) 1,230 (83.4)
Number of genotypes, mean (range) 1.54 (1–4) 1.38 (1–5) 0.047
Number of infections, n(%)
 Single 48 (61.5) 182 (74.3) 0.030
 Multiple (>1) 30 (38.5) 63 (25.7)
All high-risk genotypes present targeted by the 4-valent HPV vaccinea, n(% of the HPV positive patients)
 Yes 8 (10.3) 52 (21.2) 0.030
 No 70 (89.7) 193 (78.8)
All high-risk genotypes present targeted by the 9-valent vaccineb, n(% of the HPV positive patients)
 Yes 42 (53.9) 155 (63.3) 0.14
 No 36 (46.1) 90 (36.7)
Presence of ≥1 high-risk genotypes targeted by the 4-valent vaccinea, n(% of the HPV positive patients)
 Yes 21 (26.9) 76 (31.0) 0.49
 No 57 (73.1) 169 (69.0)
Presence of ≥1 high-risk genotypes targeted by the 9-valent vaccineb, n(% of the HPV positive patients)
 Yes 61 (78.2) 194 (79.2) 0.85
 No 17 (21.8) 51 (20.8)
  1. aTargeting HPV6, HPV11, HPV16 and HPV18. HPV6 and HPV11 are low-risk genotypes and not included in this analysis
  2. bTargeting HPV6, HPV11, HPV16, HPV18, HPV31, HPV33, HPV45, HPV52, and HPV58. HPV6, and HPV11 are low-risk genotypes and not included in this analysis